Morquio syndrome (mucopolysaccharidosis IV B) associated with beta-galactosidase deficiency. Report of two cases
- PMID: 6446239
- PMCID: PMC1686002
Morquio syndrome (mucopolysaccharidosis IV B) associated with beta-galactosidase deficiency. Report of two cases
Abstract
Two male patients, aged 6 and 25, both with normal intelligence and absence of neurological abnormalities, exhibited dysostosis multiplex, dwarfism, odontoid anomalies, cloudy corneas, exessive excretion of keratan sulfate, and abnormal urinary oligosaccharides. Leukocytes and fibroblasts of both patients were deficient in acid beta-galactosidase (beta-gal) and normal in N-acetylgalactosamine-6-sulfate sulfatase, the deficient enzyme in classical Morquio syndrome. The beta-gal deficiency was not due to an endogenous inhibitor, and the parents exhibited intermediate activities. Deficient beta-gal activity was observed toward p-nitrophenyl-beta-galactoside, 4-methylumbelliferyl-beta-galactoside (4 MU-beta-gal), lactose, GM1 ganglioside, keratan sulfate, and asialofetuin (ASF). Under standard assay conditions, the residual activity was similar for all substrates tested. Toward p-nitrophenyl-beta-glactoside, the mutant enzyme behaved as a Km variant.
Similar articles
-
Morquio-B disease, spondyloepiphyseal dysplasia associated with acid beta-galactosidase deficiency. Report of three cases in one family.Hum Genet. 1983;64(1):50-4. doi: 10.1007/BF00289478. Hum Genet. 1983. PMID: 6409799
-
Morquio B syndrome: a primary defect in beta-galactosidase.Am J Med Genet. 1983 Oct;16(2):261-75. doi: 10.1002/ajmg.1320160215. Am J Med Genet. 1983. PMID: 6418007
-
Imbalanced substrate specificity of mutant beta-galactosidase in patients with Morquio B disease.Mol Genet Metab. 2003 Jan;78(1):51-8. doi: 10.1016/s1096-7192(02)00199-3. Mol Genet Metab. 2003. PMID: 12559848
-
[Structural basis for β-galactosidase associated with lysosomal disease].Yakugaku Zasshi. 2013;133(5):509-17. doi: 10.1248/yakushi.13-00001-1. Yakugaku Zasshi. 2013. PMID: 23649392 Review. Japanese.
-
Morquio B Disease. Disease Characteristics and Treatment Options of a Distinct GLB1-Related Dysostosis Multiplex.Int J Mol Sci. 2020 Nov 30;21(23):9121. doi: 10.3390/ijms21239121. Int J Mol Sci. 2020. PMID: 33266180 Free PMC article. Review.
Cited by
-
Molecular Mechanisms in Pathophysiology of Mucopolysaccharidosis and Prospects for Innovative Therapy.Int J Mol Sci. 2024 Jan 17;25(2):1113. doi: 10.3390/ijms25021113. Int J Mol Sci. 2024. PMID: 38256186 Free PMC article. Review.
-
A homozygous missense arginine to histidine substitution at position 482 of the beta-galactosidase in an Italian infantile GM1-gangliosidosis patient.Hum Genet. 1992 Nov;90(3):247-50. doi: 10.1007/BF00220071. Hum Genet. 1992. PMID: 1487238
-
Morquio-B disease: Clinical and genetic characteristics of a distinct GLB1-related dysostosis multiplex.JIMD Rep. 2019 Nov 28;51(1):30-44. doi: 10.1002/jmd2.12065. eCollection 2020 Jan. JIMD Rep. 2019. PMID: 32071837 Free PMC article.
-
Morquio-B disease, spondyloepiphyseal dysplasia associated with acid beta-galactosidase deficiency. Report of three cases in one family.Hum Genet. 1983;64(1):50-4. doi: 10.1007/BF00289478. Hum Genet. 1983. PMID: 6409799
-
Morquio-B syndrome (MPS-IV B) associated with beta-galactosidase deficiency in two siblings.Indian J Pediatr. 2002 Jan;69(1):109-11. doi: 10.1007/BF02723790. Indian J Pediatr. 2002. PMID: 11876111
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials